Filter your results
- 4
- 4
- 4
- 1
- 3
- 4
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 3
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
Letter: how can we reduce mortality in elderly patients with acute severe ulcerative colitis? Authors' replyAlimentary Pharmacology & Therapeutics (Suppl), 2020, 51 (12), pp.1445-1446. ⟨10.1111/apt.15776⟩
Journal articles
hal-02872376v1
|
||
Systematic review with meta-analysis: mortality in acute severe ulcerative colitisAlimentary Pharmacology & Therapeutics (Suppl), 2020, 51 (1), pp.8-33. ⟨10.1111/apt.15592⟩
Journal articles
hal-02872351v1
|
|||
Systematic review with meta-analysis: comparative risk of lymphoma with anti-tumour necrosis factor agents and/or thiopurines in patients with inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics (Suppl), 2020, ⟨10.1111/apt.16050⟩
Journal articles
hal-03915508v1
|
|||
Efficacy and Safety of Combination Targeted Therapies in Immune-Mediated Inflammatory Disease: The COMBIO StudyDigestive and Liver Disease, 2023, 55 (1), pp.61-68. ⟨10.1016/j.dld.2022.07.012⟩
Journal articles
hal-03760906v1
|